These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29049198)

  • 1. Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China.
    Jiang W; Li Y; Ou J; Wang X; Zhang C; Yi L; Xue L; Zhang M
    Medicine (Baltimore); 2017 Oct; 96(42):e8155. PubMed ID: 29049198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of MTDH and VEGF in triple-negative breast cancer].
    Tan L; Qin H; Piao Y; Liu Z; Han Y; Song F; Xie X
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):827-32. PubMed ID: 26887512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
    Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
    Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer.
    Tang D; Xu S; Zhang Q; Zhao W
    Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of CD9, CD29 and epithelial to mesenchymal transition in triple-negative breast cancer.
    Ondruššek R; Brychtová S; Bezděková M; Bouchalova K; Vávrová Z; Souček K; Bouchal J
    Klin Onkol; 2024; 38(1):50-56. PubMed ID: 39183551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.
    Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS
    Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].
    Guan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):196-9. PubMed ID: 18756935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.
    Liu JB; Feng CY; Deng M; Ge DF; Liu DC; Mi JQ; Feng XS
    World J Surg Oncol; 2017 Aug; 15(1):139. PubMed ID: 28764784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
    Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
    Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of biological markers as potential therapeutic targets in Saudi women with triple-negative breast cancer.
    Sayed-Ahmed MM; Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Aleisa AM; Al-Yahya AA; Alsheikh A; Al Diab AI; Al-Akeely MH
    Tumori; 2013; 99(4):545-54. PubMed ID: 24326846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
    Zhang J; Wang Y; Yin Q; Zhang W; Zhang T; Niu Y
    Int J Clin Exp Pathol; 2013; 6(7):1380-91. PubMed ID: 23826420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
    Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
    Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
    Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
    Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer.
    Zhou Y; Li G; Wu J; Zhang Z; Wu Z; Fan P; Hao T; Zhang X; Li M; Zhang F; Li Q; Lu B; Qiao L
    Tumour Biol; 2010 Dec; 31(6):549-58. PubMed ID: 20563765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Egr3 genetic polymorphisms and coronary artery disease in the Uygur and Han of China.
    Li X; Ma YT; Xie X; Yang YN; Ma X; Zheng YY; Pan S; Liu F; Chen BD
    Lipids Health Dis; 2014 May; 13():84. PubMed ID: 24886494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
    Gao H; Lan X; Li S; Xue Y
    Tumour Biol; 2017 May; 39(5):1010428317698368. PubMed ID: 28459196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
    Ricciardi GR; Adamo B; Ieni A; Licata L; Cardia R; Ferraro G; Franchina T; Tuccari G; Adamo V
    PLoS One; 2015; 10(6):e0128368. PubMed ID: 26039245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.